6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 29 20:38
Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 13 19:13
Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 23 21:14
Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 1, 2023 20:00
Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 1, 2023 19:00
Silence Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 2, 2023 04:31
Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jul 11, 2023 19:00
Silence Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jul 3, 2023 19:30
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
May 4, 2023 19:41
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
May 1, 2023 19:31
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 28, 2023 04:31
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 28, 2023 20:00
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 13, 2023 05:30
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 7, 2022 21:30
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 29, 2022 20:00
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 12, 2022 18:07
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 15, 2022 05:20
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
May 16, 2022 20:30
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 25, 2022 20:31
Silence Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 4, 2022 20:31
No Data
No Data